Robert J Geraghty

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Venues

Viruses

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

PLoS neglected tropical diseases

University of Minnesota System

University of Wisconsin Madison (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Minnesota System May 15 2008

United States

Professor :: Center for Drug Design

Education History

University of Wisconsin Madison

United States

PHD :: Oncology

University of Minnesota

United States

BSC :: Genetics and Cell Biology

Publications

Zhengqiang Wang, Robert J Geraghty
Viral Nucleases. Viruses 15 (3) (2023)
Ryuichi Majima, Tiffany C Edwards, Christine D Dreis, Robert J Geraghty, Laurent F Bonnac
Enhanced Remdesivir Analogues to Target SARS-CoV-2. Molecules (Basel, Switzerland) 28 (6) (2023)
Zhengqiang Wang, Robert J Geraghty
Viral Nucleases. Viruses 15 (3) (2023)
Ajit Dhananjay Jagtap, Robert J Geraghty, Zhengqiang Wang
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds. Journal of medicinal chemistry (2023)
Ryuichi Majima, Tiffany C Edwards, Christine D Dreis, Robert J Geraghty, Laurent F Bonnac
Enhanced Remdesivir Analogues to Target SARS-CoV-2. Molecules (Basel, Switzerland) 28 (6) (2023)
Zhengqiang Wang, Robert J Geraghty
Viral Nucleases. Viruses 15 (3) (2023)
Ryuichi Majima, Tiffany C Edwards, Christine D Dreis, Robert J Geraghty, Laurent F Bonnac
Enhanced Remdesivir Analogues to Target SARS-CoV-2. Molecules (Basel, Switzerland) 28 (6) (2023)
Eunkyung Jung, Ruben Soto-Acosta, Robert J Geraghty, Liqiang Chen
Zika Virus Inhibitors Based on a 1,3-Disubstituted 1 H -Pyrazolo[3,4- d ]pyrimidine-amine Scaffold. Molecules (Basel, Switzerland) 27 (18) (2022)
Tianyu He, Tiffany C Edwards, Jiashu Xie, Hideki Aihara, Robert J Geraghty, Zhengqiang Wang
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. Journal of medicinal chemistry 65 (7) (2022)
Eunkyung Jung, Ruben Soto-Acosta, Jiashu Xie, Daniel J Wilson, Christine D Dreis, Ryuichi Majima, Tiffany C Edwards, Robert J Geraghty, Liqiang Chen
Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase. ACS medicinal chemistry letters 13 (9) (2022)
Yan Wang, Ruben Soto-Acosta, Rui Ding, Liqiang Chen, Robert J Geraghty
Anti-HCMV activity by an irreversible p97 inhibitor LC-1310. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents (2021)
Robert J Geraghty, Matthew T Aliota, Laurent F Bonnac
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses 13 (4) (2021)
Ruben Soto-Acosta, Eunkyung Jung, Li Qiu, Daniel J Wilson, Robert J Geraghty, Liqiang Chen
4,7-Disubstituted 7H-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus. Molecules (Basel, Switzerland) 26 (13) (2021)
Ruben Soto-Acosta, Tiffany C Edwards, Christine D Dreis, Venkatramana D Krishna, Maxim C-J Cheeran, Li Qiu, Jiashu Xie, Laurent F Bonnac, Robert J Geraghty
Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies. Viruses 13 (12) (2021)
Jing Wu, Jinzhu Zhang, Ruben Soto-Acosta, Lili Mao, Jiahui Lian, Kenny Chen, Guy Pillon, Guoqi Zhang, Robert J Geraghty, Shengping Zheng
One-Pot Synthesis of 1-Hydroxyacridones from para-Quinols and ortho-Methoxycarbonylaryl Isocyanates. The Journal of organic chemistry 85 (6) (2020)
Li Qiu, Steven E Patterson, Laurent F Bonnac, Robert J Geraghty
Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis. PLoS neglected tropical diseases 12 (4) (2018)
Yan Wang, Lili Mao, Jayakanth Kankanala, Zhengqiang Wang, Robert J Geraghty
Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage. Journal of virology 91 (3) (2017)

Robert J Geraghty.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert J Geraghty